NAC Safety Docket Provides US FDA Cover From Acknowledging Preclusion Error, CRN Contends

“Single legal issue” is “whether the drug preclusion provision … properly precludes NAC from being marketed in dietary supplements,” CRN says in latest comment. Other stakeholders submit comments noting numerous studies showing NAC safety and decades of use in food products.